The doxorubicin market is expected to grow at a CAGR of 6.1% during the forecast period of 2024 to 2032.The global market for doxorubicin, a critical chemotherapy agent in the battle against various cancers, is set to witness substantial growth. This growth is primarily fueled by the increasing incidence of cancer worldwide, continuous improvements in chemotherapy technologies, and expanding accessibility ...
Read More »